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Dietary (n-3) long chain polyunsaturated fatty acids inhibit ischemia and 
reperfusion arrhythmias and infarction in rat heart not enhanced by ischemic 
preconditioning 
Abstract 
Ischaemic preconditioning is a powerful cardioprotective phenomenon. Cardioprotection afforded by 
(n-3) polyunsaturated fatty acids (PUFA) also suggests preconditioning-like effects. This study examined 
the effects of dietary fish oil on heart function and injury during myocardial ischemia and reperfusion and 
interactions between diet and ischemic preconditioning (IP). Male Wistar rats were fed diets containing 
10% fat by weight including either 7% fish oil + 3% olive oil (n-3) PUFA); 5% sunflower seed oil + 5% olive 
oil ((n-6) PUFA); or 7% saturated fat-rich beef tallow + 3% olive oil (SF) for 6 weeks. Isolated perfused 
hearts subjected to 30min regional ischemia were reperfused for 120min, with or without prior IP as three 
cycles of 5min global ischemia. Spontaneous resting heart rate, coronary flow, and end diastolic pressure 
were significantly lower in (n-3) PUFA hearts than (n-6) PUFA or SF. In reperfusion (n-3) PUFA hearts had 
significantly less arrhythmia, and better recovery of developed pressure and maximum rate of relaxation. 
Infarct size was significantly smaller in (n-3) PUFA hearts (10.9±0.6% ischemic zone, n=6) than (n-6) PUFA 
(47.4±0.3%, n=6) or SF (50.3±0.3%, n=6). IP significantly reduced arrhythmias and improved heart function 
similar to but significantly less than (n-3) PUFA diet alone. Infarct size was equally reduced by IP or (n-3) 
PUFA diet. IP did not further improve heart function or ischemic recovery in (n-3) PUFA hearts. Dietary fish 
oil provides nutritional preconditioning to the heart, providing as powerful or better cardioprotection than 
ischaemic preconditioning in facilitating post-ischemic recovery and limiting cardiac injury and 
myocardial infarction. 
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Nutritional preconditioning by dietary (n-3) long chain polyunsaturated
fatty acids protects the heart against ischemic damage
Abstract
Ischaemic preconditioning is a powerful cardioprotective phenomenon. Cardioprotection afforded by (n-3)
polyunsaturated fatty acids (PUFA) also suggests preconditioning-like effects. This study examined the effects
of dietary fish oil on heart function and injury during myocardial ischemia and reperfusion and interactions
between diet and ischemic preconditioning (IP). Male Wistar rats were fed diets containing 10% fat by weight
including either 7% fish oil + 3% olive oil (n-3) PUFA); 5% sunflower seed oil + 5% olive oil ((n-6) PUFA);
or 7% saturated fat-rich beef tallow + 3% olive oil (SF) for 6 weeks. Isolated perfused hearts subjected to
30min regional ischemia were reperfused for 120min, with or without prior IP as three cycles of 5min global
ischemia. Spontaneous resting heart rate, coronary flow, and end diastolic pressure were significantly lower in
(n-3) PUFA hearts than (n-6) PUFA or SF. In reperfusion (n-3) PUFA hearts had significantly less
arrhythmia, and better recovery of developed pressure and maximum rate of relaxation. Infarct size was
significantly smaller in (n-3) PUFA hearts (10.9±0.6% ischemic zone, n=6) than (n-6) PUFA (47.4±0.3%,
n=6) or SF (50.3±0.3%, n=6). IP significantly reduced arrhythmias and improved heart function similar to
but significantly less than (n-3) PUFA diet alone. Infarct size was equally reduced by IP or (n-3) PUFA diet.
IP did not further improve heart function or ischemic recovery in (n-3) PUFA hearts. Dietary fish oil provides
nutritional preconditioning to the heart, providing as powerful or better cardioprotection than ischaemic
preconditioning in facilitating post-ischemic recovery and limiting cardiac injury and myocardial infarction.
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Nutritional preconditioning by dietary (n-3) long chain polyunsaturated fatty acids 
protects the heart against ischemic damage. 
Grace G Abdukeyum, Alice J Owen, Peter L McLennan 
Abstract: 
Ischaemic preconditioning is a powerful cardioprotective phenomenon. Cardioprotection 
afforded by (n-3) polyunsaturated fatty acids (PUFA) also suggests preconditioning-like effects. 
This study examined the effects of dietary fish oil on heart function and injury during 
myocardial ischemia and reperfusion and interactions between diet and ischemic 
preconditioning (IP). Male Wistar rats were fed diets containing 10% fat by weight including 
either 7%  fish oil + 3% olive oil (n-3) PUFA); 5% sunflower seed oil + 5% olive oil ((n-6) 
PUFA); or 7% saturated fat-rich beef tallow + 3% olive oil (SF) for 6 weeks.  Isolated perfused 
hearts subjected to 30min regional ischemia were reperfused for 120min, with or without prior 
IP as three cycles of 5min global ischemia.  Spontaneous resting heart rate, coronary flow, and 
end diastolic pressure were significantly lower in (n-3) PUFA hearts than (n-6) PUFA or SF. In 
reperfusion (n-3) PUFA hearts had significantly less arrhythmia, and better recovery of 
developed pressure and maximum rate of relaxation.  Infarct size was significantly smaller in 
(n-3) PUFA hearts (10.9±0.6% ischemic zone, n=6) than (n-6) PUFA (47.4±0.3%, n=6) or 
SF (50.3±0.3%, n=6). IP significantly reduced arrhythmias and improved heart function 
similar to but significantly less than (n-3) PUFA diet alone. Infarct size was equally reduced by 
IP or (n-3) PUFA diet. IP did not further improve heart function or ischemic recovery in (n-3) 
PUFA hearts.  Dietary fish oil provides nutritional preconditioning to the heart, providing as 
powerful or better cardioprotection than ischaemic preconditioning in facilitating post-ischemic 
recovery and limiting cardiac injury and myocardial infarction.  
  
Key words: ischemic preconditioning; arrhythmia; heart rate; hemodynamics; ischemia; 
reperfusion; infarct size; fish oil; dietary lipids 
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Introduction: 
Dietary omega-3 (n-3) polyunsaturated fatty acids (PUFA)
1
 provide cardiovascular 
protection, with regular intake of (n-3) long chain PUFA through fish or fish oil 
associated with reduced mortality from heart disease in both epidemiological studies 
and clinical trials (1-4). Experimental evidence suggests that regular consumption of (n-
3) PUFA is particularly effective in protecting against the damaging effects of 
myocardial ischemia (‘heart attack’). Clinical intervention and animal studies have 
shown (n-3) PUFA to be associated with prevention of fatal cardiac arrhythmias that 
can occur following an ischemic episode (‘sudden heart attack death’), even though the 
incidence of ischemic events may not be affected (5,6). Animal studies have shown 
enhanced early post-ischemic recovery of heart function, and provide indirect evidence 
of protection against ischemia-reperfusion injury (7,8) .  
 
An alternative approach to deliver cardioprotection may be through the phenomenon of 
ischemic preconditioning, wherein brief periods of acute myocardial ischemia provide 
some protection for the heart against the damaging effects of subsequent prolonged 
episodes of ischemia. Ischemic-preconditioning (IP), which was first demonstrated in 
dogs (9), has subsequently been confirmed in rats, rabbits and other animal models.  Its 
demonstration in humans has invigorated a search to establish a viable means of 
utilising preconditioning therapeutically (10). The protective influences of ischemic 
preconditioning include lower heart muscle oxygen demand, improved recovery of post-
                                                     
1
 Abbreviations used: AA, arachidonic acid; ALA, alpha linolenic acid; AS, arrhythmia score; 
DHA, docosahexaenoic acid; DPA, docosapentaenoic acid; ECG, electrocardiogram; EFA, essential 
fatty acid; EPA, eicosapentaenoic acid; FO, fish oil; GRAS, generally regarded as safe; IP, ischemic 
preconditioning; LA, linoleic acid; MI, myocardial infarction; n.d., not detected; PUFA, 
polyunsaturated fatty acid; sat, saturated fat; SF saturated fat diet VF, ventricular fibrillation; 
VPB, ventricular premature beats; VT, ventricular tachycardia 
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ischemic heart function, reduction in the incidence of ischemia-reperfusion induced 
arrhythmia, and reduction of infarct size, (11-14).  
 
Ischemia generates numerous metabolites, autacoids and cell signalling molecules that 
can act as triggers of preconditioning (15), and many are under investigation for the 
potential development of therapeutic approaches to preconditioning, so called 
pharmacological preconditioning (16,17).  Despite advances in identifying 
pharmacological approaches to mimic ischemic preconditioning, their lack of cardiac 
specificity and inherent potential for side effects, together with poor prospects of 
predicting ischemic episodes, brings into question the feasibility of such an approach 
and largely limits their potential use to specific situations such as during coronary artery 
bypass graft and other planned cardiac surgery. 
 
The clinical and epidemiological evidence for cardioprotective effects of fish oil, 
together with specific experimental evidence of preconditioning–like effects on heart 
function suggests that (n-3) PUFA provide a form of protection that might be seen as 
nutritional equivalent of ischemic preconditioning. This study aimed to evaluate the 
efficacy of dietary fish oil in providing cardioprotection under the same conditions as 
ischemic preconditioning and to evaluate their potential synergy.  It specifically tested 
the hypothesis that (n-3) PUFA would provide sustained recovery of myocardial 
function and reduce infarct size following ischemia-reperfusion.  This is preparatory to 
investigating the cell signalling mechanisms underpinning (n-3) PUFA-mediated 
cardioprotection. A dietary approach with a safe and effective nutritional component 
could overcome the need to predict the onset of ischemic episodes, which currently 
constrains the potential effectiveness of pharmacological therapies. 
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Methods: 
Fifty four male Wistar rats were randomly assigned to three dietary groups. They 
received, for 6 weeks, one of three iso-energetic diets containing either predominantly 
saturated fat, (n-6) PUFA or (n-3) PUFA based on the American Institute of Nutrition 
AIN97 rat diet, containing all essential vitamins and minerals but with gelatine 
replacing casein as part of the protein source. Animals were fed fabricated diets based 
on the AIN-97 M diet (18) containing (% dry weight) 57% cornstarch, 10% sucrose, 9% 
casein, 5% gelatine, 5% cellulose, 10% oil, 3.5% mineral mix and 1% vitamin mix (19). 
The diet provided 64.6% of energy (%en) as carbohydrate, 13.6%en as protein and 
22%en as fat. The fatty acid profile of each diet is shown in table 1. All diets were 
consumed iso-energetically by the rats, delivering a similar total fat intake to all 
animals.  The diet was prepared with 10% (dry wt) fat consisting of 7% fish oil  
(NuMega high DHA tuna fish oil) plus 3% olive oil ((n-3) PUFA diet) or 5% sunflower 
seed oil  plus 5% olive oil ((n-6) PUFA diet) or 7% beef tallow  plus 3% olive oil  (SF 
diet).  All diets contained sufficient PUFA to prevent EFA deficiency. The oil blends in 
the (n-3) PUFA diet and the (n-6) PUFA diet were designed to deliver similar total 
PUFA. Gelatine was included in place of some casein to permit the diets to be mixed 
wet then set in trays at 4°C, sliced into cubes and kept frozen at –20°C until use. 
Animal care and experiments were conducted with the approval of the local animal 
ethics committee according to the guidelines of the National Health and Medical 
Research Council, Australia, Australian Code of Practice for the Care and Use of 
Animals for Scientific Purposes (20).  Following six weeks of feeding, rats were 
anesthetised with pentobarbital sodium (60mg/kg
-1 
i.p.) and their hearts were rapidly 
 6 
removed through a thoracic incision by transecting all major vessels, and then 
submerged in cold perfusate to arrest beating. 
The heart was subsequently attached to a perfusion apparatus via the aorta; perfusion 
was initiated immediately with Krebs-Henseleit bicarbonate buffer (NaCl 118mM, KCl 
4.7mM, MgSO4.7H2O 1.6mM, KH2PO4 1.2 mM, NaHCO3 24.9 mM, CaCl 2.5mM, and 
glucose 11.1mM). The solution was gassed with 5%CO2 in O2 at 37°C. The myocardial 
temperature was maintained near 37°C throughout the experiment. The heart was 
perfused in the Langendorff mode under constant pressure of 75 mmHg set by adjusting 
the height of the reservoir. A thin walled fluid-filled plastic balloon catheter connected 
to a pressure transducer (Cobe) was introduced into the left ventricle via the left atrium. 
Balloon volume was adjusted to produce an end diastolic pressure of 6-8mmHg. Left 
ventricular haemodynamics were constantly monitored using data acquisition and 
processing program Lab View for Windows (National Instruments).  
Hearts were allowed to beat spontaneously and equilibrated for 30min and then baseline 
measurements of cardiac function were taken prior to initiation of ischemia. Coronary 
flow was measured by timed collection of the coronary effluent. Heart Rate, maximum 
rate of pressure development, maximum rate of relaxation and left ventricular developed 
pressure were determined by analysing pressure tracings using Lab View for Windows.  
The electrocardiogram (ECG) was recorded and ventricular tachycardia (VT) was 
assessed as four or more consecutive beats of similar morphology with no preceding P 
wave and with a basic cycle length at least 20% less than that of prevailing complexes.  
Ventricular fibrillation (VF) was assessed as chaotic morphology of the repetitive 
complexes for at least four cycles accompanied by a precipitous drop in developed 
pressure.  Arrhythmias were additionally assessed by counting the number of ventricular 
premature beats (VPB) and the incidence and total duration of all episodes of VT 
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(Ventricular Tachycardia) and VF (Ventricular fibrillation).  Global severity of 
arrhythmias was assessed using hierarchical scores for ischemia and reperfusion (6). 
The score awarded points on a hierarchical scale of 0-9. A score of 0-5 represents 
increasing degrees of reverting arrhythmias. A score of 6-9 represents the occurrence of 
non-reverting VF of progressively earlier onset. 
Control experiments commenced with 30min equilibration, after which regional 
ischemia was induced by occluding the left anterior descending coronary artery for 
30min, followed by release of the occluding ligature and 120min reperfusion. 
Separate groups of hearts were subjected to an ischemic preconditioning protocol prior 
to 30min ischemia. This consisted of three cycles of 5min global ischemia, each 
followed by 5min reperfusion before the onset of 30min regional ischemia, then 120min 
reperfusion. On completion of the reperfusion period, the coronary artery was re-
occluded and the heart was infused with Evans Blue dye to reveal the ischemic zone 
(unstained region of the heart). Hearts were sliced and incubated in a buffer containing 
triphenyl-tetrazolium chloride and sodium phosphate (pH 7.4), then stored in 10% 
formalin until photographed and analysed for infarct size using the Imager program. 
Infarct size was reported as a percentage of the zone at risk. 
 
Data Handling and Statistical Analysis 
Results were expressed as mean ± SEM. For each parameter, the effects of ischemic 
preconditioning and dietary treatment were tested by 2-way repeated-measures analysis 
of variance (ANOVA) with individual between-diet comparisons by Tukey’s post hoc 
test. The percent of isolated hearts acutely exhibiting spontaneous, sustained ventricular 
tachycardia (VT) or ventricular fibrillation (VF) was scored during ischemia or 
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reperfusion and group contrasts were tested by Fisher’s exact test. Values were 
considered to be significantly different at P<0.05. 
 
 
Results 
Effects of diet at equilibrium 
Under control isovolumic conditions at equilibrium, compared with the saturated fat 
(Fig 1a) and (n-6) PUFA hearts (Fig 1b), the (n-3) PUFA hearts exhibited significantly 
lower coronary flow (P<0.001) (Fig 1c), spontaneous heart rate (Fig 2c) that was ≥20 
beats.min
-1
 lower (P<0.01) than SF (Fig 2a) or (n-6) PUFA (Fig 2b) and ≥30 mmHg 
greater developed pressure (Fig 1f) (P<0.01) compared to SF (Fig 1d) or (n-6) PUFA  
(Fig 1e). These heart functions were not significantly different between SF and (n-6) 
PUFA hearts. The maximum rate of ventricular relaxation was significantly greater in 
(n-3) PUFA (Fig 4c) (p<0.01) than the SF (Fig 4a) or (n-6) PUFA hearts (Fig 4b).  The 
end diastolic pressure, which was initially set at 6-8mmHg in all hearts, was 
significantly lower in the (n-3) PUFA hearts (Fig 3c) (P<0.01) after equilibration than in 
SF (Fig 3a) and (n-6) PUFA hearts (Fig 3b).  The maximum rate of ventricular pressure 
development (Fig 4a-c) and the rate-pressure product, which is the product of heart rate 
and systolic pressure (data not shown), were not significantly different between dietary 
groups at equilibrium.  
 
Effects of Ischemic Preconditioning on Heart Function at Equilibrium 
After three 5min periods of global ischemic preconditioning, ventricular developed 
pressure increased significantly in the SF (Fig 1a) and (n-6) PUFA hearts (Fig 1b) 
(P<0.05), as did maximum rate of relaxation (Fig 4a,b) (P<0.05). End diastolic pressure 
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was significantly lower (Fig 3a,b) (P<0.05) compared to control SF and (n-6) PUFA 
hearts at equilibrium.  Coronary flow and spontaneous heart rate tended to be lower but 
the differences did not reach significance.  There were no significant differences 
between ischemia-preconditioned and control hearts in the (n-3) PUFA group (P>0.05) 
for any measure of heart function. 
 
Effects of Regional Ischemia and Reperfusion 
Occlusion of the left anterior descending coronary artery reduced the coronary flow 
producing regional ischemia in all hearts (Fig 1a-c).  Measures of heart function, left 
ventricular developed pressure (Fig 1d-f), heart rate (Fig 2), rate pressure product (data 
not shown) and maximum rates of pressure development and relaxation (Fig 4) were 
significantly reduced in all hearts during ischemia (P<0.001). End diastolic pressure 
rose significantly in all hearts during ischemia (Fig 3) (P<0.001). 
 
When the occlusion was released to allow reperfusion, coronary flow rapidly increased 
to a mean of 131.5 ± 3.4% of the pre-occlusion level across all diets, then returned 
gradually towards the equilibrium value over time (Fig 1a-c). Measures of heart 
function including: heart rate (Fig 2), left ventricular developed pressure (Fig 1d-f), rate 
pressure product (data not shown) and maximum rates of pressure development and 
relaxation (Fig 4), all returned towards equilibrium values after reperfusion. The end 
diastolic pressure, which was elevated during ischemia, remained significantly elevated 
for the entire 120-min of reperfusion in all groups (Fig 3) (P<0.001). 
 
Cardiac arrhythmias were common during ischemia, with 59% and 41% of all control 
hearts exhibiting ventricular tachycardia or ventricular fibrillation respectively. All 
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episodes of VT and VF spontaneously reverted to sinus rhythm. On reperfusion, 
ventricular tachycardia and ventricular fibrillation occurred in 63% and 37% of hearts 
respectively (Table 2). 
 
Effects of diet on responses to Ischemia and Reperfusion 
Coronary artery occlusion reduced coronary flow by a similar percentage in all dietary 
groups, leaving residual flows of 78.2 ± 2.1% (SF); 70 ± 3.1%,((n-6) PUFA); and 71 ± 
2.2% ((n-3) PUFA) in each of the dietary control groups. During ischemia and 
reperfusion, the (n-3) PUFA control hearts exhibited significantly lower coronary flow 
(Fig 1c), significantly lower spontaneous heart rate (Fig 2c), significantly higher 
developed pressure (Fig 1d) compared with the SF and (n-6) PUFA control hearts 
(P<0.01), which were not significantly different to each other.  The maximum rate of 
ventricular relaxation was also greater in (n-3) PUFA than the SF and (n-6) PUFA 
groups (Fig 4) (P<0.01). The end diastolic pressure, which did become elevated during 
ischemia, remained significantly lower in the (n-3) PUFA hearts during ischemia and 
reperfusion (Fig 3c) than in SF (Fig 3a) or (n-6) PUFA hearts (Fig 3b) (P<0.01). The 
rate pressure product was not significantly different between dietary groups during 
ischemia and reperfusion (data not shown). The incidence of the arrhythmias VT and 
VF during both ischemia and reperfusion was significantly lower in (n-3) PUFA hearts 
than in the SF hearts (P<0.05) (Table 2). The duration of arrhythmia episodes in (n-3) 
PUFA hearts also tended to be lower but the very low occurrence prevented statistical 
comparison. The cumulative arrhythmia score was significantly lower in (n-3) PUFA 
control hearts compared with either SF and (n-6) PUFA control hearts in ischemia 
(P<0.05) and reperfusion (P<0.05) and n-6 PUFA arrhythmia score was significantly 
lower than SF in ischemia (Table 2)  
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Effects of Preconditioning on responses to Ischemia and Reperfusion 
Ischemic-preconditioning significantly influenced cardiac function during reperfusion 
with lower coronary flow (P<0.05) (Fig 1), heart rate (P<0.05) (Fig 2) and a reduced 
rise in end diastolic pressure (P<0.05) (Fig 3). Developed pressure (P<0.05) (Fig 1) and 
maximum rate of ventricular relaxation were also higher in reperfusion after 
preconditioning (P<0.05) (Fig 4). These changes were observed in the SF and (n-6) 
PUFA hearts but not in the (n-3) PUFA hearts. For example, the developed pressure 
remained higher during ischemia in preconditioned SF and (n-6) PUFA hearts compared 
to control hearts and recovered to a level not significantly different to the equilibrium 
levels during reperfusion. There were no significant differences in developed pressure 
during ischemia or reperfusion between preconditioned and control (n-3) PUFA hearts 
(P>0.05).  The incidence of arrhythmias VT and VF in ischaemia or reperfusion tended 
to be lower after preconditioning but did not reach significance (P=0.27-0.32).  The 
episodes of VT or VF were of shorter duration (P<0.05) following preconditioning, and 
cumulative arrhythmia scores were significantly lower in both ischemia (P<0.05)  and 
reperfusion (P<0.05)  (Table 2). 
Effects of Diet and Preconditioning on Infarct size 
       The infarct size as percent ischemic zone at risk was significantly smaller in (n-3) 
PUFA hearts than in SF or (n-6) PUFA hearts (P<0.05) (Fig 5). There were no 
significant differences in infarct size between (n-6) PUFA and SF hearts. There was no 
difference in the zone at risk between groups (data not shown), indicating that the 
degree of ischemia was equivalent. 
        Ischemic-preconditioning significantly reduced infarct size in SF (P<0.05) and (n-
6) PUFA hearts (P<0.05) representing approximately 35% reduction compared with 
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control hearts. There were no significant differences in infarct size between 
preconditioned and control (n-3) PUFA hearts (P>0.05)(Fig 5). 
Discussion 
The present study demonstrates that dietary (n-3) PUFA fish oil protects the rat heart 
against myocardial infarction when hearts are subjected to occlusion of a major 
coronary artery, in a manner simulating an acute heart attack.   Mechanistically this 
cardioprotection must occur within the myocardium following fatty acid incorporation 
into cellular membranes, since neither blood platelets nor fatty acids were circulating in 
the isolated heart perfusate (21).  The 6-week feeding period undertaken in the present 
study exceeds the two to four weeks feeding required for the level of the major 
myocardial (n-3) PUFA, DHA to reach equilibrium within cellular membranes (19).  
Previous indirect evidence for (n-3) PUFA limitation of lethal myocellular injury, 
through the reduced release of cellular markers of damage in ischemia such as creatine 
kinase (8,22,23) was directly established in this study.  Reduced infarct size is regarded 
as the ultimate indicator of cardioprotection by ischemic preconditioning (24) and in 
this study ischemic preconditioning also significantly reduced infarct size after 
ischemia-reperfusion in SF and (n-6) PUFA hearts. However, while infarction was 
equally inhibited by ischemic preconditioning or fish oil feeding, the infarct size was 
not further reduced by the concurrent imposition of ischemic preconditioning in (n-3) 
PUFA hearts. Fish oil feeding therefore appears to produce “dietary” or “nutritional” 
preconditioning equivalent to ischemic preconditioning in terms of infarct protection.     
In the early stages of regional myocardial ischemia, before myocellular damage 
becomes fatal (infracted), heart function (especially relaxation and filling of diastolic 
heart function) becomes depressed.  Ventricular end diastolic pressure gradually rises as 
hearts become stiff and less amenable to relaxation, and a high proportion of hearts 
become arrhythmic.  Reduced rates of pressure fall after each beat and elevated end 
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diastolic pressure between heart beats are indicative of poor ability of the heart to relax 
and fill.  However, in (n-3) PUFA hearts, the characteristic ischemia-induced rise in end 
diastolic pressure was less pronounced, arrhythmias were largely absent, and functional 
recovery during subsequent reperfusion was enhanced relative to SF and (n-6) PUFA 
hearts.  Similarly, in ischemic preconditioned hearts, the end diastolic pressure remained 
low during ischemia and reperfusion and functional recovery was enhanced, but this 
was only evident in the SF and (n-6) PUFA hearts.  These findings show that while both 
(n-3) PUFA and ischemic preconditioning protected the heart against the adverse effects 
of prolonged ischemia, the effects were not additive or synergistic.  Indeed, in terms of 
arrhythmia generation, diastolic relaxation and end diastolic pressure, fish oil feeding 
produced greater cardioprotection than acute ischemic preconditioning alone.  The 
isolated perfused hearts were free of circulating fatty acids throughout the in vitro 
evaluation of cardiac function, indicating that the fish oil effects were dependent on the 
prior incorporation of the (n-3) fatty acids into cellular membranes (6-8,22).  
 
Ischemic preconditioning reduces the severity of reperfusion arrhythmias in the rat heart 
(13) and enhances the recovery of contractile function of the myocardial region-at-risk in 
rabbits (11). Importantly, we can demonstrate that neither the effects of nutritional- nor 
ischemic-preconditioning were attributable to differences in degree of ischemia, or 
variations in collateral flow, since all hearts exhibited equivalent reductions in coronary 
blood flow during the regional ischemia. This implied a similar ischemic region size in all 
hearts, which was later confirmed in stained slices.  Paradoxically, both the (n-3) PUFA 
diet and ischemic-preconditioning reduced coronary flow at rest and during reperfusion, 
indicative of reduced myocardial oxygen delivery.  When considered together with the 
maintained or enhanced contractile function, this suggests improved energy efficiency. 
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Both dietary fish oil  (8,22) and ischemic preconditioning (14,25) have previously been 
shown to reduce myocardial oxygen consumption of the heart.  
 
The mechanism of the antiarrhythmic effects (observed with either ischemic 
preconditioning (12,13) or dietary fish oil in isolated hearts, in whole animals and in human 
studies(6,8,26-28)) is still not clear. It has been suggested that ischemic preconditioning 
may attenuate electrophysiological effects associated with calcium-overload during 
ischemia and reperfusion and thereby protect against arrhythmias (29) and mitochondrial 
damage (30).  Reduced intracellular calcium overload is also implicated in the 
cardiovascular protective effects of fish oil, affecting both arrhythmias and mitochondrial 
function (8,31).  Modulation of the slowed maximum rate of relaxation and elevated end 
diastolic pressure by either ischemic preconditioning or dietary fish oil in the present study 
also suggests altered intracellular calcium handling during ischemia (32).  These findings 
support the suggestion that both ischemic and nutritional preconditioning might decrease or 
delay calcium overload by affecting calcium influx, efflux or intracellular redistribution. 
Further support for the involvement of calcium handling in the cardioprotective effects of 
ischemic preconditioning and (n-3) PUFA is provided by the low resting heart rate 
observed in (n-3) PUFA hearts in this study and that seen in the human heart in association 
with regular fish intake (33).  Low heart rate is associated with reduced cardiovascular risk, 
including reduced risk of sudden death (34). Although heart rate may be influenced by 
many physiological mechanisms, evidence is accumulating that (n-3) PUFA modulate 
calcium channels(28). The in vitro nature of the present study isolates these effects from 
changes in autonomic nervous function or peripheral vascular effects that could contribute 
in vivo to reduce heart rate.(35). 
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The low coronary flow observed in (n-3) PUFA hearts occurring without detriment to cardiac 
function concurs with the low oxygen demand and high coronary flow reserve of those hearts 
(8,22).  Underlying changes in mitochondrial metabolism may contribute to more efficient 
oxygen utilization in (n-3) PUFA hearts. Increased energy utilisation efficiency is similarly 
evident after ischemic preconditioning (14,25).  Reduced rates of mitochondrial respiration 
are seen in hearts from fish oil fed rats (31) and membrane fatty acid modulation may modify 
a number of intracellular and membrane events. Thus, dietary fat modulation of calcium 
handling through altered cardiac membrane composition may affect oxygen use and 
arrhythmia vulnerability (8). 
Since discovery of the powerful protective effects of ischemic preconditioning in 
animals and humans, research has focussed on identification of intracellular mediators 
and development of pharmacological mimetic agents to provide a therapeutic approach 
that might reliably protect the heart from ischemic insult (36,37).   Examples of 
ischemic preconditioning mimetic agents include adenosine, adenosine agonists, protein 
kinase C agonists, KATP channel openers, and NO donors (38).  These agents are 
effective when given just prior to an ischemic episode to produce a genuine 
preconditioning effect, however, the need for administration of such agents immediately 
ahead of the onset of ischemia is a problem for clinical application, since the occurrence 
of an acute out of hospital ischemia event is rarely predictable.  Such agents are also 
largely non-specific for myocardium and may produce unwanted side-effects unless 
administered by direct cardiac infusion. Dietary fish oil on the other hand, has long been 
classified by the US-FDA as “generally regarded as safe” (GRAS) and has a history of 
safe consumption associated with both primary and secondary cardioprotection.  Fish 
oils are rich sources of the long chain (n-3) (or omega-3) PUFA; eicosapentaenoic acid 
(EPA, 20:5n-3) and docosahexaenoic acid (DHA, 22:6n-3). Because eating fish oil leads 
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to sustained elevated incorporation of DHA into myocardial membrane phospholipids 
(39), the evidence of cardioprotection persisting for periods of feeding ranging from 6 
weeks in the present study and for longer periods ranging from four to 30 months 
(8,6,40) with regular fish or fish oil consumption, the (n-3) PUFA can be present at all 
times prior to any unexpected ischemic episode. 
 
Dietary fish oil induces changes in membrane fatty acid composition that are sustained with 
regular consumption and produces cardioprotection that appears similar to ischemic 
preconditioning that by virtue of the continuous presence of (n-3) PUFA in myocardial 
membranes is not reliant on prediction of imminent ischemic episodes.  Therefore, in light of 
its cardioprotective effects to reduce the consequences of ischemic events in the human 
population when a regular part of the diet (7,8,41), the (n-3) PUFA provided by dietary fish 
or fish oils may be effective “nutritional preconditioning” agents. Unlike pharmacological 
mimicking of ischemic preconditioning (3,42), nutritional preconditioning would require no 
prediction or prior knowledge of ischemic events and could thus represent a low-risk solution 
to ischemic cardioprotection.  
 
Over the past decade or more, the protective cardiovascular effects of fish consumption have 
often been described and are now firmly established (43).  Human intervention trials in post-
infarction patients demonstrate reduced mortality with regular intake of fish or fish oil, 
without changes in blood pressure, blood lipids or, most significantly, without reductions in 
new cardiac events (44).  These observations support a preconditioning-like effect, rather 
than the more obvious reduction in coronary atherosclerosis and prevention of new ischemic 
episodes.  Nutritional preconditioning by membrane incorporation of (n-3) fatty acids may 
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underpin the low cardiovascular morbidity and mortality associated with regular fish and fish 
oil consumption. 
 
Literature cited 
1. Valagussa F, Franzosi MG, Geraci E, Mininni N, Nicolosi GL, Santini M, Tavazzi L, 
Vecchio C, Marchioli R, Bomba E et al. Dietary supplementation with n-3 polyunsaturated fatty 
acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo 
Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. Lancet. 1999;354:447-455. 
2. Kromhout D, Bosschieter EB,de Lezenne Coulander C The inverse relation between fish 
consumption and 20-year mortality from coronary heart disease. N Engl J Med. 1985;312:1205-
1209. 
3. Burr ML, Fehily AM,Gilbert JF Effects of changes in fat, fish, and fibre intakes on death and 
myocardial reinfarction: diet and reinfarction trial (DART). Lancet. 1989;2:757-761. 
4. Albert CM, Campos H, Stampfer MJ, Ridker PM, Manson JE, Willett WC,Ma J Blood levels 
of long-chain n-3 fatty acids and the risk of sudden death. N Engl J Med. 2002;346:1113-1118. 
5. Marchioli R, Barzi F, Bomba E,Chieffo C Early protection against sudden death by n-3 
polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the 
Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-
Prevenzione.[see comment]. Circulation. 2002;105:1897-1903. 
6. McLennan PL, Abeywardena MY,Charnock JS Dietary fish oil prevents ventricular 
fibrillation following coronary artery occlusion and reperfusion. American Heart Journal. 
1988;116:709-717. 
7. Pepe S,McLennan PL Dietary fish oil confers direct antiarrhythmic properties on the 
myocardium of rats. J Nutr. 1996;126:34-42. 
8. Pepe S,McLennan PL Cardiac membrane fatty acid composition modulates myocardial 
oxygen consumption and postischemic recovery of contractile function. Circulation. 
2002;105:2303-2308. 
9. Murry CE, Jennings RB,Reimer KA Preconditioning with ischemia: a delay of lethal cell 
injury in ischemic myocardium. Circulation. 1986;74:1124-1136. 
10. Yellon DM,Downey JM Preconditioning the Myocardium: From Cellular Physiology to 
Clinical Cardiology. Physiol Rev. 2003;83:1113-1151. 
 20 
11. Cohen MV, Liu GS,Downey JM Preconditioning causes improved wall motion as well as 
smaller infarcts after transient coronary occlusion in rabbits. Circulation. 1991;84:341-349. 
12. Hagar JM, Hale SL,Kloner RA Effect of preconditioning ischemia on reperfusion 
arrhythmias after coronary artery occlusion and reperfusion in the rat. Circ Res. 1991;68:61-68. 
13. Shiki K,Hearse DJ Preconditioning of ischemic myocardium: reperfusion-induced 
arrhythmias. Am J Physiol. 1987;253:H1470-1476. 
14. Tanoue Y, Herijgers P, Meuris B, Verbeken E, Leunens V, Lox M,Flameng W Ischemic 
preconditioning reduces unloaded myocardial oxygen consumption in an in-vivo sheep model. 
Cardiovasc Res. 2002;55:633-641. 
15. Cohen MV, Baines CP,Downey JM Ischemic preconditioning: from adenosine receptor to 
KATP channel. Ann Rev Physiol. 2000;62:79-109. 
16. Szekeres L Drug-induced delayed cardiac protection against the effects of myocardial 
ischemia. Pharmacol Therap. 2005;108:269-280. 
17. Kloner RA,Rezkalla SH Preconditioning, postconditioning and their application to clinical 
cardiology. Cardiovasc Res. 2006;70:297-307. 
18. Reeves PG Components of the AIN-93 Diets as Improvements in the AIN-76A Diet. J Nutr. 
1997;127:838S–841S. 
19. Owen AJ, Peter-Przyborowska BA, Hoy AJ,McLennan PL Dietary fish oil dose- and time-
response effects on cardiac phospholipid fatty acid composition. Lipids. 2004;39:955-961. 
20. Australian Code of Practice for the Care and Use of Animals for Scientific Purposes, 7th ed. 
National Health and Medical Research Council, Canberra, 2004 pp84 
21. Zhu BQ, Sievers RE, Sun YP, Morse-Fisher N, Parmley WW,Wolfe CL Is the reduction of 
myocardial infarct size by dietary fish oil the result of altered platelet function? Am Heart J. 
1994;127:744-755. 
22. Pepe S,Mclennan PL (n-3) long chain PUFA dose-dependently increase oxygen utilization 
efficiency and inhibit arrhythmias after saturated fat feeding in rats. J Nutr. 2007;137:2377-
2383. 
 21 
23. Landmark K, Abdelnoor M, Urdal P, Kilhovd B, Dorum HP, Borge N,Refvem H Use of fish 
oils appears to reduce infarct size as estimated from peak creatine kinase and lactate 
dehydrogenase activities. Cardiology. 1998;89:94-102. 
24. Liu Y,Downey JM Ischemic preconditioning protects against infarction in rat heart. Am J 
Physiol. 1992;263:H1107-1112. 
25. Monnet X, Ghaleh B, Lucats L, Colin P, Zini R, Hittinger L,Berdeaux A Phenotypic 
adaptation of the late preconditioned heart: Myocardial oxygen consumption is reduced. 
Cardiovasc Res. 2006;70:391-398. 
26. Nair SS, Leitch JW, Falconer J,Garg ML Prevention of cardiac arrhythmia by dietary (n-3) 
polyunsaturated fatty acids and their mechanism of action. J Nutr. 1997;127:383-393. 
27. Hirafuji M, Machida T, Hamaue N,Minami M Cardiovascular protective effects of n-3 
polyunsaturated fatty acids with special emphasis on docosahexaenoic acid. J Pharmacol Sci. 
2003;92:308-316. 
28. McLennan PL,Abeywardena MY Membrane basis for fish oil effects on the heart: linking 
natural hibernators to prevention of human sudden cardiac death. J Memb Biol. 2005;206:85-
102. 
29. Zhu J,Ferrier GR Ischemic preconditioning: antiarrhythmic effects and electrophysiological 
mechanisms in isolated ventricle. Am J Physiol. 1998;274:H66-75. 
30. Argaud L, Gateau-Roesch O, Chalabreysse L, Gomez L, Loufouat J, Thivolet-Bejui F, 
Robert D,Ovize M Preconditioning delays Ca2+-induced mitochondrial permeability transition. 
Cardiovasc Res. 2004;61:115-122. 
31. Pepe S, Tsuchiya N, Lakatta EG,Hansford RG PUFA and aging modulate cardiac 
mitochondrial membrane lipid composition and Ca2+ activation of PDH. Am J Physiol. 
1999;276:H149-158. 
32. Gao WD, Atar D, Backx PH,Marban E Relationship between intracellular calcium and 
contractile force in stunned myocardium. Direct evidence for decreased myofilament Ca2+ 
responsiveness and altered diastolic function in intact ventricular muscle. Circ Res. 
1995;76:1036-1048. 
 22 
33. Mozaffarian D, Geelen A, Brouwer IA, Geleijnse JM, Zock PL,Katan MB Effect of fish oil 
on heart rate in humans - A meta-analysis of randomized controlled trials. Circulation. 
2005;112:1945-1952. 
34. Jouven X, Zureik M, Desnos M, Guerot C,Ducimetiere P Resting heart rate as a predictive 
risk factor for sudden death in middle-aged men. Cardiovasc Res. 2001;50:373-378. 
35. Grimsgaard S, Bonaa KH, Hansen JB,Myhre ES Effects of highly purified eicosapentaenoic 
acid and docosahexaenoic acid on hemodynamics in humans. Am J Clin Nutr. 1998;68:52-59. 
36. Baines CP, Wang L, Cohen MV,Downey JM Myocardial protection by insulin is dependent 
on phospatidylinositol 3-kinase but not protein kinase C or KATP channels in the isolated rabbit 
heart. Basic Res Cardiol. 1999;94:188-198. 
37. Vanden Hoek TL, Becker LB, Shao Z, Li C,Schumacker PT Reactive oxygen species 
released from mitochondria during brief hypoxia induce preconditioning in cardiomyocytes. J 
Biol Chem. 1998;273:18092-18098. 
38. Downey JM,Cohen MV Signal transduction in ischemic preconditioning. Adv Exp Med 
Biol. 1997;430:39-55. 
39. Bolli R The late phase of preconditioning. Circ Res. 2000;87:972-983. 
40. McLennan PL, Barnden LR, Bridle TM, Abeywardena MY,Charnock JS Dietary fat 
modulation of left ventricular ejection fraction in the marmoset due to enhanced filling. 
Cardiovasc Res. 1992;26:871-877. 
41. McLennan PL Myocardial membrane fatty acids and the antiarrhythmic actions of dietary 
fish oil in animal models. Lipids. 2001;36 Suppl:S111-114. 
42. Marchioli R, Schweiger C, Tavazzi L,Valagussa F Efficacy of n-3 polyunsaturated fatty 
acids after myocardial infarction: results of GISSI-Prevenzione trial. Gruppo Italiano per lo 
Studio della Sopravvivenza nell'Infarto Miocardico. Lipids. 2001;36 Suppl:S119-126. 
43. Cohen MV, Yang X-M, Liu GS, Heusch G,Downey JM Acetylcholine, Bradykinin, 
Opioids, and Phenylephrine, but not Adenosine, Trigger Preconditioning by Generating Free 
Radicals and Opening Mitochondrial KATP Channels. Circ Res. 2001;89:273-278. 
 23 
44. Kris-Etherton PM, Harris WS,Appel LJ Fish consumption, fish oil, omega-3 fatty acids, and 
cardiovascular disease. Circulation. 2002;106:2747-2757. 
 
 
 24 
Fig 1 
Influence of dietary supplements and Ischemic Preconditioning (IP) on coronary flow 
(a, b, c) and left ventricular developed pressure (d, e, f) during 30min ischemia and 
120min reperfusion in rat isolated, spontaneously beating hearts.  Filled symbols: 
control groups, open symbols: preconditioned groups. (a,d) saturated fat diet: ●○ ; (b,e) 
(n-6) PUFA diet: ▲∆; (c,f) (n-3) PUFA diet ■□. Filled bar on time-axis shows 30min 
ischemia duration.  Results are expressed as mean ± SEM. n=6-9.  Ischemic 
preconditioning vs control within dietary group (* P < 0.05).  (n-3) PUFA vs saturated 
fat and (n-6) PUFA dietary groups (# P < 0.01).  
 
Fig 2 
Influence of dietary supplements and Ischemic Preconditioning on heart rate during 
30min ischemia and 120min reperfusion in rat isolated, spontaneously beating hearts. 
Filled symbols: control groups, open symbols: preconditioned groups.  (a) saturated fat 
diet: ●○ ; (b) (n-6) diet: ▲∆; (c) (n-3) diet ■□.  Filled bar on time-axis shows 30min 
ischemia duration. Results are expressed as mean ± SEM. n=6-9.  Ischemic 
preconditioning vs control within dietary group (* P < 0.05).  (n-3) PUFA vs saturated 
fat and (n-6) PUFA dietary groups (# P < 0.01). 
 
Fig 3  
Influence of dietary supplements and Ischemic Preconditioning on left ventricular end 
diastolic pressure (EDP) during 30min ischemia and 120min reperfusion in rat isolated 
spontaneously beating hearts. Filled symbols: control groups, open symbols: 
preconditioned groups.  (a) saturated fat diet: ●○ ; (b) (n-6) diet: ▲∆; (c) (n-3) diet ■□.  
Filled bar on time-axis shows 30min ischemia duration. Results are expressed as mean ± 
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SEM. n=6-9.  Ischemic preconditioning vs control within dietary group (* P < 0.05).  
(n-3) PUFA vs saturated fat and (n-6) PUFA dietary groups (# P < 0.01). 
 
Fig 4  
Influence of dietary supplements and Ischemic Preconditioning on maximum rate of 
contraction +dP/dtmax and maximum rate of relaxation –dP/dtmax during 30min ischemia 
and 120min reperfusion in rat isolated spontaneously beating hearts. Filled symbols: 
control groups, open symbols: preconditioned groups.  (a,d) saturated fat diet: ●○ ; (b,e) 
(n-6) diet: ▲∆; (c,f) (n-3) diet ■□.  Filled bar on time-axis shows 30min ischemia 
duration. Results are expressed as mean ± SEM. n=6-9.  Ischemic preconditioning vs 
control within dietary group (* P < 0.05).  (n-3) PUFA vs saturated fat and (n-6) PUFA 
dietary groups (# P < 0.01). 
 
Fig 5 
Influence of dietary supplements and Ischemic Preconditioning (IP) on infarct size after 
30min ischemia and 120min reperfusion in rat isolated hearts. Speckled bars: control 
groups, square hatched bars: preconditioned groups.  Results are expressed as mean ± 
SEM. n=6.  Ischemic preconditioning vs control within dietary group (* P < 0.05).  (n-
3) PUFA vs saturated fat and (n-6) PUFA dietary groups (# P < 0.05). 
 *: Significant difference to same dietary group preconditioned (p<0.05).  
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Table 1. 
Fatty acid composition of rat diets 
 (n-3) PUFA (n-6) PUFA SF 
% FO 7.0%   
% SSO  5%  
% beef tallow   7% 
% OO 3.0% 5% 3% 
  g/kg of diet  
12:0   0.6 
14:0 2.1 0 2.6 
16:0 17.1 8.1 20.6 
16:1 3.4 0.4 3.2 
18:0 4.5 3.6 14.1 
18:1 (OA) 33.5 50.0 47.9 
18:2 n-6 (LA) 3.5 36.0 4.7 
18:3 n-3 (LNA) 0.6 0.5 0.6 
20:4 n-6 (AA) 1.3 n.d 0.1 
20:5 n-3 (EPA) 4.9 n.d n.d 
22:5 n-3 (DPA) 0.8 n.d n.d 
22:6 n-3 (DHA) 20.2 n.d n.d 
    
Total sat 25.5 12.6 38.1 
Total Mono 39.2 50.6 51.4 
Total PUFA 31.4 36.6 5.4 
     Total (n-6) PUFA 5.0 36.2 4.8 
     Total  (n-3) PUFA 26.4 0.5 0.6 
P:S ratio 1.14 3.18 0.25 
(n-6):(n-3) PUFA ratio 0.19 74 8.3 
P:S ratio = polyunsaturated to saturated fatty acid ratio
Incidence and duration of ventricular tachycardia (VT) and ventricular fibrillation (VF), and on arrhythmia score (AS) during 30min 
ischemia or 120min reperfusion in rat isolated spontaneously beating hearts.  
SF:  saturated fat diet; (n-6) PUFA: (n-6) polyunsaturated fatty acid diet; (n-3): (n-3) polyunsaturated fatty acid diet; %: percent of 
animals. Duration of VT or VF represents the total duration in seconds of all episodes that occurred in each heart. Hearts with no VT or 
VF episodes could not be included for duration analysis.  Results are expressed as mean ± SEM or % incidence.  n=9 per dietary group 
except durations, where n= 0-8.n.d. not detected.  * Significantly different Ischemic Preconditioning vs control within dietary group (P < 
Table 2. Influence of diet and ischaemic preconditioning on cardiac arrhythmias 
in ischemia and reperfusionControl 
Preconditioned 
 Diet n %VT Duration of 
VT (s) 
%VF Duration of 
VF (s) 
    AS n %VT Duration of 
VT (s) 
%VF Duration of 
VF (s) 
AS 
SF 9 89 39.6 ±5.5 78 38.7 ±7.1 4.8 ±0.4 9 67 *24.0 ± 2.1 44 12.7 ±0.8 *3.5 ±0.2 
(n-6) PUFA 9 67 18.5 ±3.4 44 12.3 ±3.4 
#
3.2 ±0.3 9 44 *7.8 ± 0.8 33 1.3 ±0.3 
#
*2.1 ±0.3 
(n-3) PUFA 9 
#
23 
ø
 9.0 ±7  
#
0 
ø
 n.d.  
†
2.0 ±0.0 9 
#
11 
ø
 2.0 ± 0.0 0 
   ø
 n.d.  
†
1.0 ±0.0 
 
 
Ischemia 
Total 27 59 27.8 ±4.3 41 28.0 ±6 3.8 ±0.3 27 41 *16.0 ± 3.0 30 *7.0 ±2.2 *3.0 ±0.2 
SF 9 88 20.1 ±4 67 29.8 ±6 4.8 ±0.5 9 56 *14.0 ± 1.8 44 *9.8 ±2.4 *3.0 ±0.2 
(n-6) PUFA 9 77 18.8 ±0.7 33 16.0 ±4.5 3.7 ±0.4 9 56 *6.4 ± 1.2 22 *7.5 ±2.5 
#
*2.0 ±0.2 
(n-3) PUFA 9 
#
22 
#
2.5 ±0.5 
#
11 
ø
 5.0  
†
2.0 ±0.0 9 11 
ø
 4.0 ± 0.0 11 
ø
 4.0 ±0.0 
†
1.0 ±0.0 
 
 
Reperfusion 
Total 27 63 17.5 ±2.3 37 23.2 ±4.6 3.9 ±0.3 27 41 *9.6 ± 1.5  26 *8.2 ±1.6 *2.3 ±0.2 
 28 
0.05).  # Significantly different to SF (P < 0.05).  † Significantly different to SF and (n-6) PUFA (P < 0.05). ø: incidence of VT or VF too 
low to conduct statistical analysis on duration; 
Figure 1.   
Figure 2. 
Figure 3 
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Figure 5 
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